Here we show that SELENBP1 is significantly down-regulated in human bladder cancer tissues and cell lines, and its frequent reduction is further associated with tumor progression as well as poor clinical outcome among patients with bladder cancer. Here, SELENBP1 is linked to urinary bladder cancer.